BackCorvus Pharmaceuticals Overview

Corvus Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for CRVS.

Quarterly EBIT

-$14.88M
↓ 49.94% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$48.37M
↓ 54.95% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin